GHX provides a wide range of perspectives on how greater collaboration and visibility across the supply chain can improve both clinical and financial performance in healthcare.
Erinn leads research development and operations at Lumere and leverages clinical and academic evidence to help hospitals manage and optimize medical device decisions.
Prior to joining Lumere, Erinn led the development of soft tissue implants for general surgery, from design through pre-clinical testing for FDA approval as a director in Research & Development at Viscus Biologics. Her work resulted in a Validation Phase for 510K clearance to market.
Erinn received a PhD in Bioengineering from the University of Pittsburgh. Her graduate research focused on the micromechanical mechanisms of fetal membrane failure. She has a Bachelor of Science in Mechanical Engineering from The Ohio State University.